These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21508332)

  • 1. CMT2A: the name doesn't tell the whole story.
    Scherer SS
    Neurology; 2011 May; 76(20):1686-7. PubMed ID: 21508332
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A.
    Cartoni R; Martinou JC
    Exp Neurol; 2009 Aug; 218(2):268-73. PubMed ID: 19427854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural mitochondrial modifications characteristic of mitofusin 2 mutations (CMT2A).
    Sole G; Ferrer X; Vital C; Martin-Negrier ML; Vital A; Latour P
    J Peripher Nerv Syst; 2009 Sep; 14(3):206-7. PubMed ID: 19909486
    [No Abstract]   [Full Text] [Related]  

  • 4. Axonal Charcot-Marie-Tooth disease: the fog is slowly lifting!
    Reilly MM
    Neurology; 2005 Jul; 65(2):186-7. PubMed ID: 16043782
    [No Abstract]   [Full Text] [Related]  

  • 5. Selective mitochondrial depletion, apoptosis resistance, and increased mitophagy in human Charcot-Marie-Tooth 2A motor neurons.
    Rizzo F; Ronchi D; Salani S; Nizzardo M; Fortunato F; Bordoni A; Stuppia G; Del Bo R; Piga D; Fato R; Bresolin N; Comi GP; Corti S
    Hum Mol Genet; 2016 Oct; 25(19):4266-4281. PubMed ID: 27506976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-occurrence of amyotrophic lateral sclerosis and Charcot-Marie-Tooth disease type 2A in a patient with a novel mutation in the mitofusin-2 gene.
    Marchesi C; Ciano C; Salsano E; Nanetti L; Milani M; Gellera C; Taroni F; Fabrizi GM; Uncini A; Pareyson D
    Neuromuscul Disord; 2011 Feb; 21(2):129-31. PubMed ID: 20951041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial coupling defect in Charcot-Marie-Tooth type 2A disease.
    Loiseau D; Chevrollier A; Verny C; Guillet V; Gueguen N; Pou de Crescenzo MA; Ferré M; Malinge MC; Guichet A; Nicolas G; Amati-Bonneau P; Malthièry Y; Bonneau D; Reynier P
    Ann Neurol; 2007 Apr; 61(4):315-23. PubMed ID: 17444508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations.
    Chung KW; Kim SB; Park KD; Choi KG; Lee JH; Eun HW; Suh JS; Hwang JH; Kim WK; Seo BC; Kim SH; Son IH; Kim SM; Sunwoo IN; Choi BO
    Brain; 2006 Aug; 129(Pt 8):2103-18. PubMed ID: 16835246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Charcot-Marie-Tooth neuropathy type 2A: novel mutations in the mitofusin 2 gene (MFN2).
    Engelfried K; Vorgerd M; Hagedorn M; Haas G; Gilles J; Epplen JT; Meins M
    BMC Med Genet; 2006 Jun; 7():53. PubMed ID: 16762064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hindlimb gait defects due to motor axon loss and reduced distal muscles in a transgenic mouse model of Charcot-Marie-Tooth type 2A.
    Detmer SA; Vande Velde C; Cleveland DW; Chan DC
    Hum Mol Genet; 2008 Feb; 17(3):367-75. PubMed ID: 17959936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mitofusin 2 as a crucial peripheral nervous system protein and a common regulator of cell metabolism].
    Kawalec M; Kotruchow K; Kochański A; Zabłocka B
    Postepy Biochem; 2011; 57(2):215-21. PubMed ID: 21913423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene.
    Lawson VH; Graham BV; Flanigan KM
    Neurology; 2005 Jul; 65(2):197-204. PubMed ID: 16043786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mitofusin 2 gene mutation causing Charcot-Marie-Tooth type 2A disease in a Chinese family.
    Ching CK; Lau KK; Yu KW; Chan YW; Mak MC
    Chin Med J (Engl); 2010 Jun; 123(11):1466-9. PubMed ID: 20819609
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression of mitofusin 2(R94Q) in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A.
    Cartoni R; Arnaud E; Médard JJ; Poirot O; Courvoisier DS; Chrast R; Martinou JC
    Brain; 2010 May; 133(Pt 5):1460-9. PubMed ID: 20418531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial fusion protein mutated in CMT2A.
    Bradbury J
    Lancet Neurol; 2004 Jun; 3(6):326. PubMed ID: 15176403
    [No Abstract]   [Full Text] [Related]  

  • 16. Genotype-phenotype correlations in Charcot-Marie-Tooth disease type 2 caused by mitofusin 2 mutations.
    Calvo J; Funalot B; Ouvrier RA; Lazaro L; Toutain A; De Mas P; Bouche P; Gilbert-Dussardier B; Arne-Bes MC; Carrière JP; Journel H; Minot-Myhie MC; Guillou C; Ghorab K; Magy L; Sturtz F; Vallat JM; Magdelaine C
    Arch Neurol; 2009 Dec; 66(12):1511-6. PubMed ID: 20008656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MFN2 mutations cause severe phenotypes in most patients with CMT2A.
    Feely SM; Laura M; Siskind CE; Sottile S; Davis M; Gibbons VS; Reilly MM; Shy ME
    Neurology; 2011 May; 76(20):1690-6. PubMed ID: 21508331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of CMT 1B due to Val 102/fs null mutation of the MPZ gene presenting as hyperCKemia.
    Luigetti M; Modoni A; Renna R; Silvestri G; Ricci E; Montano N; Tasca G; Papacci M; Monforte M; Conte A; Pomponi MG; Sabatelli M
    Clin Neurol Neurosurg; 2010 Nov; 112(9):794-7. PubMed ID: 20537790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment: The increasing complexity of phenotype-genotype correlations in CMT.
    Glass JD
    Neurology; 2011 Jul; 77(2):171. PubMed ID: 21715704
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of disease: a molecular genetic update on hereditary axonal neuropathies.
    Züchner S; Vance JM
    Nat Clin Pract Neurol; 2006 Jan; 2(1):45-53. PubMed ID: 16932520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.